BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for March 28, 2023

March 28, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bimini Health, Biocorp, Cryoport, Digital Diagnostics, Freenome, Health2sync, Infandx, Novo Nordisk, Prelude, Seegene, Sqi Diagnostics.
Read More

In the clinic for March 28, 2023

March 28, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Pulnovo Medical.
Read More

Financings for March 28, 2023

March 28, 2023
Med-tech firms raising money in public or private financings, including: Jin Medical, Kayentis, Sirius Medical.
Read More

Appointments and advancements for March 28, 2023

March 28, 2023
New hires and promotions in the med-tech industry, including: Cerevasc, Conventus Flower Orthopedics, Elucid, Omnimed.
Read More

Regulatory actions for March 21-28, 2023

March 28, 2023
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Aurion, Boan, FSD, Henlius, Jiangsu Recbio, Luye, Mesoblast, Olix, Prestige.
Read More

Other news to note for March 28, 2023

March 28, 2023
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Asahi Kasei, Basilea, Beigene, Biorchestra, Brii, CASI, Devshealth, Enveric, Everest Medicines, F-star, Gilead Sciences, Immunomedics, Ingenū, Invox, Jacobio, Joincare, Macomics, Merck, Ono, Peptidream, Psyence, Rayzebio, Sino, Taigen, Takeda.
Read More

In the clinic for March 21-27, 2023

March 28, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astellas, Kangpu, Kintor, Transcenta.
Read More

Regulatory actions for March 28, 2023

March 28, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amicus, Brainstorm Cell, Cyclerion, Genentech, Incyte, Iovance, Oncology.
Read More

Other news to note for March 28, 2023

March 28, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, AMT, Argenx, Astellas, Astrazeneca, BJ, Boehringer Ingelheim, Chr. Hansen, Hepalink, Covant, Cytomx, Mallinckrodt, Micurx, Mimetas, Novozyme, Noxopharm, Oncovent, Oncoverity, Orient Europharma, Osivax, Regeneron, Salipro, Scineuro, Secarna, Silence, Sonoma and Zura.
Read More

In the clinic for March 28, 2023

March 28, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Baudaxbio, Eyepoint, Imvax, Ionis, Janssen, Neuraly, Novartis, Novo Nordisk, Nrx, Ocugen, Olix, TME, Unity, Yishengbio.
Read More
Previous 1 2 … 816 817 818 819 820 821 822 823 824 … 1786 1787 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 27, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

    BioWorld Science
    Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing